Literature DB >> 14993294

Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development.

Nick Carpino1, William E Thierfelder, Ming-shi Chang, Chris Saris, Steven J Turner, Steven F Ziegler, James N Ihle.   

Abstract

The murine cytokine thymic stromal lymphopoietin (TSLP) supports the development of B220+ IgM+ immature B cells and induces thymocyte proliferation in vitro. Human TSLP, by contrast, activates CD11c+ dendritic cells, but not B or T cells. Recent studies have demonstrated that the receptor for TSLP consists of a heterodimer of the interleukin 7 (IL-7) alpha chain and a novel protein that resembles the hematopoietic cytokine receptor common gamma chain. We examined signal transduction by the gamma-like chains using chimeric receptor proteins. The cytoplasmic domain of the human, but not of the murine, gamma-like chain, activates Jak2 and Stat5 and supports the proliferation of hematopoietic cell lines. In order to assess the role of the murine gamma-like chain in vivo, we generated gamma-like chain-deficient mice. Receptor-deficient mice are unresponsive to TSLP but exhibit no obvious phenotypic defects. In particular, hematopoietic cell development appeared normal. B-cell development, including the IgM+ compartment, was unaffected by loss of the TSLP pathway, as were T lymphopoiesis and lymphocyte proliferation in vitro. Cytokine receptors that utilize the common gamma chain signal through the lymphocyte-specific kinase Jak3. Mice deficient in Jak3 exhibit a SCID phenotype but harbor a residual B220+ splenic lymphocyte population. We demonstrate here that this residual lymphocyte population is lost in mice lacking both the gamma-like chain and Jak3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993294      PMCID: PMC355866          DOI: 10.1128/MCB.24.6.2584-2592.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism.

Authors:  S D Levin; R M Koelling; S L Friend; D E Isaksen; S F Ziegler; R M Perlmutter; A G Farr
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

2.  Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

Authors:  S Y Park; K Saijo; T Takahashi; M Osawa; H Arase; N Hirayama; K Miyake; H Nakauchi; T Shirasawa; T Saito
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

3.  Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain.

Authors:  K Fujio; T Nosaka; T Kojima; T Kawashima; T Yahata; N G Copeland; D J Gilbert; N A Jenkins; K Yamamoto; T Nishimura; T Kitamura
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

4.  Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction.

Authors:  D E Isaksen; H Baumann; P A Trobridge; A G Farr; S D Levin; S F Ziegler
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  Defective lymphoid development in mice lacking Jak3.

Authors:  T Nosaka; J M van Deursen; R A Tripp; W E Thierfelder; B A Witthuhn; A P McMickle; P C Doherty; G C Grosveld; J N Ihle
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

6.  Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro.

Authors:  R J Ray; C Furlonger; D E Williams; C J Paige
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

Review 7.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

8.  Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3.

Authors:  D C Thomis; C B Gurniak; E Tivol; A H Sharpe; L J Berg
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

9.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Authors:  J J Peschon; P J Morrissey; K H Grabstein; F J Ramsdell; E Maraskovsky; B C Gliniak; L S Park; S F Ziegler; D E Williams; C B Ware; J D Meyer; B L Davison
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

Authors:  U von Freeden-Jeffry; P Vieira; L A Lucian; T McNeil; S E Burdach; R Murray
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  65 in total

Review 1.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4.

Authors:  Masanori Iseki; Miyuki Omori-Miyake; Whitney Xu; Xiaocui Sun; Satoshi Takaki; David J Rawlings; Steven F Ziegler
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

3.  Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses.

Authors:  Ryan P Larson; Simone C Zimmerli; Michael R Comeau; Andrea Itano; Miyuki Omori; Masanori Iseki; Conrad Hauser; Steven F Ziegler
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.

Authors:  Yrina Rochman; Mohit Kashyap; Gertraud W Robinson; Kazuhito Sakamoto; Julio Gomez-Rodriguez; Kay-Uwe Wagner; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation.

Authors:  Joao G Magalhaes; Stephen J Rubino; Leonardo H Travassos; Lionel Le Bourhis; Wei Duan; Gernot Sellge; Kaoru Geddes; Karou Geddes; Colin Reardon; Matthias Lechmann; Leticia A Carneiro; Thirumahal Selvanantham; Jorg H Fritz; Betsy C Taylor; David Artis; Tak Wah Mak; Michael R Comeau; Michael Croft; Stephen E Girardin; Dana J Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-19       Impact factor: 11.205

6.  Murine B-1 B cell progenitors initiate B-acute lymphoblastic leukemia with features of high-risk disease.

Authors:  Encarnacion Montecino-Rodriguez; Katy Li; Michael Fice; Kenneth Dorshkind
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

Review 7.  TSLP in epithelial cell and dendritic cell cross talk.

Authors:  Yong-Jun Liu
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

8.  Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; J Racquel Collins-Underwood; Letha A A Phillips; Michael G Loudin; Wei Liu; Jinghui Zhang; Jing Ma; Elaine Coustan-Smith; Richard C Harvey; Cheryl L Willman; Fady M Mikhail; Julia Meyer; Andrew J Carroll; Richard T Williams; Jinjun Cheng; Nyla A Heerema; Giuseppe Basso; Andrea Pession; Ching-Hon Pui; Susana C Raimondi; Stephen P Hunger; James R Downing; William L Carroll; Karen R Rabin
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

9.  Genomics based analysis of interactions between developing B-lymphocytes and stromal cells reveal complex interactions and two-way communication.

Authors:  Jenny Zetterblad; Hong Qian; Sasan Zandi; Robert Månsson; Anna Lagergren; Frida Hansson; David Bryder; Nils Paulsson; Mikael Sigvardsson
Journal:  BMC Genomics       Date:  2010-02-12       Impact factor: 3.969

10.  Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Ralpha and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation.

Authors:  Jun Zhong; Akhilesh Pandey
Journal:  BMC Immunol       Date:  2010-02-08       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.